ZA200808462B - Sulfonyl-3-heterocyclindazole derivatives as 5-hydroxytrpt-amine-6 ligands - Google Patents

Sulfonyl-3-heterocyclindazole derivatives as 5-hydroxytrpt-amine-6 ligands

Info

Publication number
ZA200808462B
ZA200808462B ZA200808462A ZA200808462A ZA200808462B ZA 200808462 B ZA200808462 B ZA 200808462B ZA 200808462 A ZA200808462 A ZA 200808462A ZA 200808462 A ZA200808462 A ZA 200808462A ZA 200808462 B ZA200808462 B ZA 200808462B
Authority
ZA
South Africa
Prior art keywords
hydroxytrpt
heterocyclindazole
sulfonyl
ligands
amine
Prior art date
Application number
ZA200808462A
Other languages
English (en)
Inventor
Kevin Liu
Albert Jean Robichaud
Jennifer Rebecca Lo
Hasssan Mahmoud Elokdah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ZA200808462B publication Critical patent/ZA200808462B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200808462A 2006-04-05 2008-10-03 Sulfonyl-3-heterocyclindazole derivatives as 5-hydroxytrpt-amine-6 ligands ZA200808462B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78953606P 2006-04-05 2006-04-05

Publications (1)

Publication Number Publication Date
ZA200808462B true ZA200808462B (en) 2010-01-27

Family

ID=38283536

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200808462A ZA200808462B (en) 2006-04-05 2008-10-03 Sulfonyl-3-heterocyclindazole derivatives as 5-hydroxytrpt-amine-6 ligands

Country Status (17)

Country Link
US (2) US7482461B2 (xx)
EP (1) EP2001865A1 (xx)
JP (1) JP2009532471A (xx)
KR (1) KR20090006148A (xx)
CN (1) CN101432274A (xx)
AU (1) AU2007235499A1 (xx)
BR (1) BRPI0709718A2 (xx)
CA (1) CA2648055A1 (xx)
CR (1) CR10339A (xx)
EC (1) ECSP088789A (xx)
GT (1) GT200800203A (xx)
IL (1) IL194365A0 (xx)
MX (1) MX2008012824A (xx)
NO (1) NO20084206L (xx)
RU (1) RU2008139078A (xx)
WO (1) WO2007117413A1 (xx)
ZA (1) ZA200808462B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201802389SA (en) * 2013-04-17 2018-04-27 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
CN113121564A (zh) * 2019-12-31 2021-07-16 韩国科学技术研究院 具有抗肿瘤效果的咪唑并恶唑衍生物及包括其的药物组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
GB9523250D0 (en) 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents
GB9523583D0 (en) 1995-11-17 1996-01-17 Merck Sharp & Dohme Therapeutic agents
AR008245A1 (es) 1996-06-21 1999-12-29 Glaxo Group Ltd Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
EP1028946A1 (en) 1997-11-04 2000-08-23 Pfizer Products Inc. Indazole bioisostere replacement of catechol in therapeutically active compounds
CN1222511C (zh) 2000-11-02 2005-10-12 惠氏公司 作为5－羟色胺－6配体的1－芳基－或1－烷基磺酰基－杂环基吲哚
EP1339708A2 (en) 2000-11-20 2003-09-03 Scios Inc. Indole-type inhibitors of p38 kinase
DE60119982T2 (de) 2000-12-22 2006-12-21 Wyeth Heterozyklylalkylindole oder -azaindole als 5-hydroxytryptamine-6 liganden
HUP0400684A2 (hu) * 2000-12-22 2004-07-28 Wyeth 5-Hidroxitriptamin-6-ligandumként használható heterociklilindazol- és -azaindazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
TW593278B (en) 2001-01-23 2004-06-21 Wyeth Corp 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
EP1385842A1 (en) 2001-04-20 2004-02-04 Wyeth Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
MXPA03009490A (es) 2001-04-20 2004-02-12 Wyeth Corp Derivados de heterociclilalcoxi-,-alquiltio-y- alquilaminobenzazol como ligando de 5-hidroxitriptamina-6.
JPWO2002100833A1 (ja) 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
EP1414442A1 (en) 2001-08-07 2004-05-06 Smithkline Beecham Plc 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
US20050113283A1 (en) 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
BRPI0308696B8 (pt) 2002-03-27 2021-05-25 Axovant Sciences Gmbh composto derivado de quinolina, seu processo de preparação, sua composição farmacêutica e seus usos
DE60309852T2 (de) 2002-03-27 2007-06-06 Glaxo Group Ltd., Greenford Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden
TW200400177A (en) 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
US7943639B2 (en) 2002-06-20 2011-05-17 Proximagen Limited Compounds
TW200403243A (en) 2002-07-18 2004-03-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
WO2004069828A1 (ja) 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation ピペリジン化合物およびその医薬用途
AU2004213374A1 (en) * 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
BRPI0407493A (pt) 2003-02-14 2006-02-14 Wyeth Corp derivados heterociclil-3-sulfinilazaindol ou -azaindazol como ligantes de 5-hidroxitriptamina-6
GB0422263D0 (en) * 2004-10-07 2004-11-10 Glaxo Group Ltd Novel compounds
EP1676841A1 (en) * 2004-12-30 2006-07-05 Esteve Laboratorios Dr. Esteve S.A. Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments

Also Published As

Publication number Publication date
EP2001865A1 (en) 2008-12-17
IL194365A0 (en) 2009-08-03
US7482461B2 (en) 2009-01-27
BRPI0709718A2 (pt) 2011-03-29
US20070238724A1 (en) 2007-10-11
NO20084206L (no) 2008-10-29
AU2007235499A1 (en) 2007-10-18
MX2008012824A (es) 2008-10-15
CN101432274A (zh) 2009-05-13
JP2009532471A (ja) 2009-09-10
KR20090006148A (ko) 2009-01-14
US20090105303A1 (en) 2009-04-23
GT200800203A (es) 2008-12-04
WO2007117413A1 (en) 2007-10-18
CR10339A (es) 2008-11-18
RU2008139078A (ru) 2010-05-10
CA2648055A1 (en) 2007-10-18
ECSP088789A (es) 2008-11-27

Similar Documents

Publication Publication Date Title
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
IL196543A0 (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
EP1973405A4 (en) HYDROXYALKYMARYLAMIDE DERIVATIVES
IL198319A0 (en) Spiroindolinone derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
EP2009005A4 (en) AZOLECARBOXAMIDE DERIVATIVE
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL195287A0 (en) 2-thioxanthine derivatives acting as mpo-inhibitors
IL196364A0 (en) Aminoindazolylurea derivatives
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
HK1136276A1 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives 5---2-
IL193211A0 (en) Indazole-heteroaryl derivatives
IL197152A0 (en) 5-phenyl-nicotinamide derivatives
EP2043633A4 (en) THIADIAZOLIDINONDERIVATE
IL197239A0 (en) Phenyloxyaniline derivatives
ZA200807460B (en) Spiroindolinone derivatives
GB0614154D0 (en) Novel Pyriazine Derivatives
ZA200808462B (en) Sulfonyl-3-heterocyclindazole derivatives as 5-hydroxytrpt-amine-6 ligands
GB0716714D0 (en) Ligands
GB0601593D0 (en) Ligands
GB0615845D0 (en) Ligand
ZA200903280B (en) 2-aminocarbonyl-pyridine derivatives
GB0610018D0 (en) Benzotriazepinone derivatives